CDSCO Panel Approves Roche's Protocol Amendment Proposal For Anti-cancer Drug Atezolizumab, Lenvatinib, and Sorafenib Study Dr. Divya Colin14 April 2024 5:15 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the drug major...
Bayer AG arm AskBio names Mansuo Shannon as Chief Scientific Officer Ruchika Sharma14 April 2024 1:00 PM ISTResearch Triangle Park: Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, has...
Arvinas, Novartis collaborate for development, commercialization of ARV-766 for prostate cancer Ruchika Sharma14 April 2024 10:00 AM ISTNew Haven: Arvinas, Inc., a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, has...
Lupin Gets CDSCO Panel Nod to Study Glycopyrronium Bromide, Vilanterol Trifenatate powder for inhalation in capsule Dr. Divya Colin13 April 2024 5:30 PM ISTNew Delhi: Reviewing the Phase IV clinical trial protocol of Lupin's pulmonary FDC (Fixed Dose Combination) Glycopyrronium Bromide plus Vilanterol...
Kenya drug regulator recalls a batch of JnJ children cough syrup Ruchika Sharma13 April 2024 4:15 PM ISTNairobi: Kenya's drug regulator said on thursday it is recalling a batch of Johnson & Johnson children's cough syrup, following...
Granules India gets Zero 483's from USFDA for Unit V facility in AP Ruchika Sharma13 April 2024 12:08 PM ISTTelangana: Granules India has informed in a BSE filing that the Company's Unit V facility located at Anakapally, Visakhapatnam, Andhra ...
USFDA concludes inspection of Lupin Dabhasa facility with no observations Ruchika Sharma13 April 2024 11:48 AM ISTMumbai: Global pharma major Lupin Limited has announced that the United States Food and Drug Administration (U.S. FDA) has completed a GMP...
Novartis tender offer for MorphoSys AG commences Ruchika Sharma12 April 2024 3:30 PM ISTBasel: Novartis has published the offer document for the voluntary public takeover offer by its wholly owned subsidiary Novartis BidCo AG for all...
SII partners with Univercells to bring affordable personalized oncology to masses Ruchika Sharma12 April 2024 2:38 PM ISTPune: In a landmark collaboration announced, Serum Institute of India (SII), the world's largest vaccine manufacturer, has joined forces with...
Roche gets CE Mark for companion diagnostic to identify patients with HER2-low metastatic breast cancer eligible for Enhertu Ruchika Sharma12 April 2024 12:54 PM ISTTucson: Roche has announced the approval of the CE Mark for the VENTANA HER2 (4B5) Rabbit Monoclonal Primary Antibody RxDx to identify...
Sun Pharma receives OAI status from USFDA for Dadra facility Ruchika Sharma12 April 2024 11:42 AM ISTMumbai: Sun Pharma has informed in a BSE filing that the US Food and Drug Administration (USFDA) has determined the inspection classification...
Roche gets USFDA Breakthrough Device Designation for blood test to support earlier Alzheimer's disease diagnosis Ruchika Sharma11 April 2024 5:47 PM ISTBasel: Roche has announced that its Elecsys pTau217 assay has received Breakthrough Device Designation from the U.S. Food and Drug Administration...
